
|Articles|June 1, 2003
Oral Valacyclovir Option
San Francisco - A one-week course of oral valacyclovir (Valtrex) appears to be a safe, effective, and economical alternative to inpatient or outpatient intravenous (IV) acyclovir (Zovirax) for treatment of immunocompromised patients with uncomplicated, acute herpes zoster virus infections, Mathijs H. Brentjens, M.D., said at the annual meeting of the American Academy of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Issues Warnings to Websites Illegally Marketing Botox and Related Products
2
Derm Dispatch at SDPA Fall 2025: How to Give Back to the PA Community as a Mentor
3
Heather C. Woolery-Lloyd, MD, FAAD, Explores the Latest Cosmeceuticals at SDPA Fall 2025
4
The Science of Sensitive Skin: Evidence-Based Cleansing and Moisturizing Practices for Protecting and Repairing the Skin Barrier: Part 1
5




















